Pulse Biosciences Gets FDA IDE for nPulse AFib Ablation Study
Pulse Biosciences, Inc. , a company leveraging its novel nPulse technology using its proprietary Nanosecond Pulsed Field Ablation energy, announced that the U.S. Food and Drug Administration (FDA) has...
